In this issue:
Add-on third-generation ASMs for focal seizures
Economic evaluation of HLA-B*15:02 genotyping for Asian Australians with epilepsy
Major congenital malformation risk after ASM exposure
Continuous intravenous anaesthetic drugs for refractory status epilepticus
Seizure recurrence in women with idiopathic generalised epilepsy after switching from valproate
Specific birth defects after ASM use in pregnant women with epilepsy
Healthcare provider burnout when caring for patients with refractory epilepsy
Brivaracetam for epilepsy stratified by comorbidities and aetiology
Clinical outcomes among initial survivors of cryptogenic NORSE
Status epilepticus in New Zealand: treatment patterns and outcome determinants
Please login below to download this issue (PDF)